Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery

Part of paid clinical trials in Fayetteville, Arkansas.

Sponsor
Vold Vision P.L.L.C
Study ID
NCT05624398
Status
Recruiting
Apply to this trial

Conditions

  • Cataract
  • Glaucoma, Open-Angle

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Vivity IOL — DEVICE
    Cataract surgery with implantation of the Vivity IOL along with concurrent implantation of the Hydrus Microstent

Study Details

This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a minimally invasive type of glaucoma surgery using a special type of stent to reduce eye pressure, with the goal of better glaucoma control and the reduction in the need for medications to control eye pressure.

Key Dates

Start date
Dec 7, 2022
Status verified
Aug 2024
Primary completion
Feb 1, 2025
Completion
May 1, 2025

Study Design

Enrollment
25 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment Group
    Subjects implanted with the Vivity IOL undergoing concurrent implantation of the Hydrus Microstent

Primary Outcome Measure

Mean Photopic Monocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR [ Time Frame: 3 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Vold Vision P.L.L.C.FayettevilleArkansas72764
Michael R. M OD
[email protected]
479-442-8653

Find similar trials in Fayetteville, AR

By research site
Vold Vision P.L.L.C.· Fayetteville, AR

Related Studies